Home › Cervical Cancer › Washington › Seattle
Cervical Cancer clinical trials in Seattle, WA
7 studies for Cervical Cancer are looking for participants at sites in and around Seattle (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
RecruitingPhase 1/2
- Fred Hutchinson Cancer Center, Seattle
Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
RecruitingPhase 1/2
- University of Washington Fred Hutchinson Cancer Center, Seattle
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RecruitingPhase 1
- University of Washington Fred Hutchinson, Seattle
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RecruitingPhase 1
- Swedish Cancer Institute, Seattle
- Swedish Medical Center, Seattle
PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer
RecruitingPhase 2
- University of Washington, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Seattle
A Study of NX-1607 in Adults With Advanced Malignancies
RecruitingPhase 1
- Fred Hutchinson Cancer Center, Seattle
About Cervical Cancer
Cervical cancer starts in the cells of the cervix, which is the lower, narrow end of the uterus. Long-lasting HPV infection causes almost all cervical cancers.
More about Cervical Cancer on MedlinePlus
Cervical Cancer trials in other cities
- Houston, TX34 studies
- New York City, NY20 studies
- Nashville, TN19 studies
- Boston, MA19 studies
- Arlington, VA18 studies
- Los Angeles, CA17 studies
- San Antonio, TX14 studies
- Dallas, TX14 studies
- St. Louis, MO12 studies
- Orlando, FL12 studies
- Columbus, OH12 studies
- Baldwin Park, CA11 studies
Other studies in Seattle
- Non-Small Cell Lung Cancer55 studies
- Cancer (all types)48 studies
- Prostate Cancer45 studies
- Acute Myeloid Leukemia40 studies
- Metastatic Cancer39 studies
- Breast Cancer37 studies
- Colorectal Cancer35 studies
- Lung Cancer34 studies
- Ovarian Cancer29 studies
- Pancreatic Cancer22 studies
- Multiple Myeloma22 studies
- Acute Lymphoblastic Leukemia22 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.